Surveillance and Health Promotion, National Center of Epidemiology, Istituto Superiore di Sanità, Rome, Italy.
Infection. 2015 Aug;43(4):431-41. doi: 10.1007/s15010-015-0747-0. Epub 2015 Feb 20.
To evaluate the association of hepatitis B virus (HBV) genotypes, basal core promoter (BCP)/precore (PC) and S gene mutations with the clinical-epidemiological characteristics of acute hepatitis B (AHB) in Italy.
During July 2005-January 2007, 103 symptomatic AHB patients were enrolled and prospectively followed up at 15 national hospitals. HBV genotypes, BCP/PC and S gene variants were determined by nested-PCR and direct sequence analysis.
Genotype D, A and F were detected in 49, 45 and 6% of patients, respectively. BCP, PC, and BCP plus PC variants were found in 3.1, 11.3 and 7.2% of patients, respectively. At enrollment, 68.3% of patients were hepatitis B e antigen (HBeAg)-positive and 31.7% HBeAg-negative. BCP/PC mutations were more common in HBeAg-negative than in HBeAg-positive patients (p < 0.0001). Compared to genotype D patients, those harboring non-D genotypes were more frequently males (p = 0.023), HBeAg-positive (p < 0.001), had higher bilirubin (p = 0.014) and viremia (p = 0.034) levels and less frequently carried BCP/PC mutations (p < 0.001). Non-D genotype patients more often were from Central Italy (p = 0.001) and reported risky sexual exposure (p = 0.021). Two patients had received vaccination before AHB: one harbored genotype F; the other showed a S gene mutation. Four patients developed fulminant AHB; mutations were found in 2 of 3 patients who underwent BCP/PC sequencing. After a 6-month follow-up, only 2 (2.8%) patients developed persistent infection.
AHB by non-D genotypes is increasing in Italy and is associated with risky sexual exposure. The ability of some genotypes to cause persistent and/or severe infection in Italy warrants larger studies for clarification.
评估乙型肝炎病毒(HBV)基因型、基本核心启动子(BCP)/前核心(PC)和 S 基因突变为意大利急性乙型肝炎(AHB)的临床流行病学特征带来的影响。
2005 年 7 月至 2007 年 1 月期间,103 名有症状的 AHB 患者在 15 家国立医院接受了前瞻性随访。通过嵌套 PCR 和直接序列分析确定 HBV 基因型、BCP/PC 和 S 基因变异。
分别在 49%、45%和 6%的患者中检测到基因型 D、A 和 F。在 3.1%、11.3%和 7.2%的患者中发现了 BCP、PC 和 BCP 加 PC 变异。入组时,68.3%的患者乙型肝炎 e 抗原(HBeAg)阳性,31.7% HBeAg 阴性。BCP/PC 突变在 HBeAg 阴性患者中比 HBeAg 阳性患者更为常见(p < 0.0001)。与基因型 D 患者相比,携带非 D 基因型的患者更常见于男性(p = 0.023)、HBeAg 阳性(p < 0.001)、胆红素(p = 0.014)和病毒血症(p = 0.034)水平更高,BCP/PC 突变率更低(p < 0.001)。非 D 基因型患者更常来自意大利中部(p = 0.001),并报告有风险的性接触(p = 0.021)。2 名患者在 AHB 前接受过疫苗接种:1 名患者携带基因型 F;另 1 名患者表现为 S 基因突变。4 名患者发展为暴发性 AHB;3 名接受 BCP/PC 测序的患者中有 2 名发现了突变。6 个月随访后,仅 2 名(2.8%)患者发生持续性感染。
意大利非 D 基因型引起的 AHB 正在增加,且与风险性行为有关。一些基因型在意大利引起持续性和/或严重感染的能力需要进一步研究加以阐明。